Recent Comments

Comment RSS

Multiple Sclerosis News and Research RSS Feed - Multiple Sclerosis News and Research

Multiple Sclerosis is an unpredictable disease of the central nervous system, multiple sclerosis (MS) can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted. Many investigators believe MS to be an autoimmune disease - one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus.

Health technology assessment to influence coverage of neurology drugs in most markets

20. November 2009 03:16
Research and Markets (http://www.researchandmarkets.com/research/60b63b/the_pricing_and_re) has announced the addition of Decision Resources, Inc.'s new report "The Pricing and Reimbursement Environment for Neurology Drugs" to their offering. [More]

Experimental drug to restore function of nerves damaged in spinal cord injuries shows promise

20. November 2009 00:04
Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , ,

First comprehensive, international baseline evidence about pandemics published

19. November 2009 07:30
Public health officials walking a tightrope between massive demand for vaccines and intense public scrutiny of side effects now have a new standard for evaluating the safety of their vaccination programs. [More]

Posted in: Disease/Infection News

Tags: , , , , ,

FDA issues complete response for Rituxan, a drug for treating chronic lymphocytic leukemia

19. November 2009 03:13
Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies’ applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL). [More]

Women with multiple sclerosis are less likely to have pregnancy complicaitons

19. November 2009 00:55
There is good news for women with multiple sclerosis (MS) who are pregnant or thinking about becoming pregnant. A new study shows that pregnant women with multiple sclerosis are only slightly more likely to have cesarean deliveries and babies with a poor prenatal growth rate than women who do not have MS. [More]

Homecare, an important part of the solution to nation's healthcare crisis

18. November 2009 06:55
During November -- National Homecare Month -- the American Association for Homecare celebrates the thousands of dedicated professionals who provide cost-effective and consumer-preferred homecare. [More]

Bayer's NEXAVAR approved in over 70 countries for the treatment of liver cancer

17. November 2009 07:35
Bayer Inc. announced today that its international trial known as SHARP (Sorafenib HCC Assessment Randomized Protocol), led by Study Manager and Bayer Canada employee Tom Giannaris, has been selected as the winner in the 'Best International Trial' category for the Global Clinical Practice Journal Awards. [More]

Assessing the neurology market and its major players

17. November 2009 04:13
Research and Markets (http://www.researchandmarkets.com/research/63cb3f/dealmaking_and_ind) has announced the addition of Decision Resources, Inc.'s new report "Dealmaking and Industry Outlook: Neurological Disease" to their offering. [More]

Phase II clinical study to evaluate Nanocort commenced

17. November 2009 03:22
Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments. [More]

Patients with pediatric-onset MS develop disabilities at a slower pace than patients with adult-onset MS: Study

17. November 2009 01:07
Magnetic resonance images (MRI) of patients diagnosed with multiple sclerosis in childhood show that pediatric onset multiple sclerosis is more aggressive, and causes more brain lesions, than MS diagnosed in adulthood, researchers at the University at Buffalo have reported. [More]

Pet therapy can have a positive effect on patients’ physical and psychosocial well being

17. November 2009 00:17
Adults who use pet therapy while recovering from total joint-replacement surgery require 50 percent less pain medication than those who do not. These findings were presented at the 18th Annual Conference of the International Society of Anthrozoology and the First Human Animal Interaction Conference (HAI) in Kansas City, Mo. [More]

Posted in: Healthcare News

Tags: , , , , , , , , ,

BrainStorm Cell's therapeutic approach has potential for treatment of neurodegenerative diseases

16. November 2009 23:25
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company’s therapeutic approach for treating neurodegenerative diseases, particularly ALS and Parkinson’s disease, was found to have a positive effect in a mouse model of multiple sclerosis (MS). [More]

Erbitux recognized as one of the major clinical cancer advances of 2009

16. November 2009 09:21
The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). [More]

Tips to ensure adequate vitamin D levels

16. November 2009 07:18
Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus. [More]

Posted in: Medical Science News

Tags: , , , , ,

CSHL solves the structure of the zinc-bound ATD domain of the NMDA receptor NR2B subunit

13. November 2009 05:17
A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor implicated in Alzheimer's, Parkinson's, and other serious illnesses. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.